Takeover Talk Surrounds Biotech Firm Alexion, Says Jim Cramer
Jim Cramer explains the recent moves in biotechs and comments on reports regarding a Justice Department investigation into generic drug makers.
Biotech stocks like Regeneron (REGN) - Get Report are rising on speculation there could be a takeover offer for Alexion Pharmaceuticals (ALXN) - Get Report , according to Jim Cramer. Cramer also commented on reports that the Department of Justice may be filing criminal charges in connection with an investigation into generic drug price collusion, saying that typically in such cases charges are filed against individual company executives and not the corporations themselves. Cramer's Action Alerts PLUS charitable trust holds stock of Allergan (AGN) - Get Report , which the Wall Street Journal reported is one of the companies being looked at by the Justice Department.
